Current Appointments & Affiliations
Clinical Data Spec III
Duke Clinical Research Institute,
Institutes and Centers
Recent Publications
Investigation of the Role of Chemical Analysis in Causality Assessment of Herbal and Dietary Supplement-Induced Liver Injury.
Journal Article Drug Saf · February 2025 BACKGROUND: The attribution of drug-induced liver injury (DILI) to specific herbal and dietary supplements (HDS) is confounded by inaccurate labels and undisclosed ingredients. The US Drug-Induced Liver Injury Network (DILIN) determines the attribution of ... Full text Link to item CiteRecurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial.
Journal Article J Am Coll Cardiol · June 30, 2020 BACKGROUND: The CABANA (Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation) trial randomized 2,204 patients with atrial fibrillation (AF) to catheter ablation or drug therapy. Analysis by intention-to-treat showed a nonsignificant ... Full text Open Access Link to item CiteFeatures and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.
Journal Article Gastroenterology · June 2015 BACKGROUND & AIMS: The Drug-Induced Liver Injury Network is conducting a prospective study of patients with DILI in the United States. We present characteristics and subgroup analyses from the first 1257 patients enrolled in the study. METHODS: In an obser ... Full text Link to item CiteRecent Grants
Drug Induced Liver Injury Network Data Coordinating Center
ResearchClinical Data Specialist · Awarded by National Institutes of Health · 2003 - 2028A Phase 1b MAD Study of TT301/MW189
Clinical TrialClinical Data Specialist · Awarded by University of Kentucky · 2017 - 2019Coordinating Center for the Drug Induced Liver Injury Network (DILIN) - Competitive Renewal
Clinical TrialClinical Data Assistant, III · Awarded by National Institutes of Health · 2008 - 2018View All Grants